ARCHIVES

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

This article is from The Cancer Letter archive.

Vol. 11 No. 15 | April 12, 1985

Download PDF Visit The Full Archive

Related Articles

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications

March 18, 1977

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Clearinghouse Agrees: Three Dyes, Hair Color Agent Are Carcinogens; Risk To Humans – Brown

May 5, 1978

Diane Fink Accepts VP Job With ACS

April 3, 1981

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997